Albemarle Q3 net sales up 152% to $2.1B; adj EPS $7.50 (+614%); tightens FY22 guidance

ALBEMARLE CORP

2022-Q3 EPS reported $13.23 revenue$4,699,126,000

Net sales $2.1B (+152% YoY); net income $897.2M; adjusted diluted EPS $7.50 (+614%).
Completed acquisition of Qinzhou lithium conversion plant in China for $200M; Kemerton II mechanically complete.
Catalysts strategic review concluded; business retained as wholly owned subsidiary branded Ketjen.
FY22 guidance tightened: net sales $7.1-$7.4B, adj EBITDA $3.3-$3.5B, adj EPS $19.75-$21.75.
Lithium net sales $1.5B (+318%), adj EBITDA $1.1B (+786%); Bromine net sales $354.9M (+28%).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ALBEMARLE CORP reported the third quarter ended September 30, 2022 results: revenue $2.1 billion, net income $897.2 million, EPS $7.61 per diluted share.

Period: the third quarter ended September 30, 2022
Revenue: $2.1 billion
Net income: $897.2 million
EPS: $7.61 per diluted share
Result: reported results

Exact text from the filing

Net sales of $2.1 billion, an increase of 152%

View on SEC.gov

Browse all earnings releases →

ALBEMARLE CORP filing history →

Source: SEC EDGAR

accession 0000915913-22-000165

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.